Stem Cell Genome Editing Series

Join us for our Stem Cell Genome Editing Series, showcasing cutting-edge advances in genome editing for stem cell biology and therapeutic development. The series reflects the Center for Genome Surgery’s mission to address critical challenges in gene editing and aligns with the UCSF Broad Stem Cell Center’s vision to Discover, Engineer, Heal. At our Feb 24 session, we will hear from speaker Serine Avagyan, MD, PhD, who will present "Multiplex mosaic CRISPR-cas9 mutagenesis in vivo."

Avagyan lab uses zebrafish to study the effect of somatic loss-of-function gene variants in genetic blood disorders. Their approach includes induction of in vivo CRISPR-cas9 mediated variants from development that results in a mosaic pattern allowing to study the clonal competition in a given tissue/cell over time.

Speaker Lineup
Feb 24 | Serine Avagyan "Multiplex mosaic CRISPR-cas9 mutagenesis in vivo"
March 10 | Alex Marson "Decoding and Reprogramming Human T Cell Circuits with CRISPR"
March 24 | Peter Bruno "Synthetic biology to enable antigen presentation screening systems"
April 28 | James Gardner "Normothermic perfusion systems as platforms for groundbreaking ex vivo human biology"
May 12 | Seth Shipman TBA

UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please contact [email protected] as soon as possible.